title: Cognitive outcome following tricyclic and electroconvulsive treatment of major depression in the elderly.
abstract: OBJECTIVE
  This study sought to ascertain the affective and cognitive outcome after tricyclic and electroconvulsive treatment of elderly medical-psychiatric patients meeting diagnostic criteria for major depression, some of whom had normal cognitive functioning and some of whom were cognitively impaired before treatment.
  
  
  METHODS
  Patients who met criteria for major depression on the basis of a structured diagnostic interview and who scored 17 or more on the Hamilton Rating Scale for Depression were evaluated with the Mattis Dementia Rating Scale. The patients were then treated in a nonrandom manner with either tricyclic antidepressants or ECT (followed by tricyclic maintenance therapy). The majority of the patients treated with ECT had not responded previously to tricyclics. Follow-up psychometric testing was repeated in 6 months.
  
  
  RESULTS
  Among the patients with normal pretreatment cognitive functioning, cognition was generally stable. Among the patients with pretreatment cognitive impairment, a substantial number--including those receiving ECT--demonstrated improvement in cognition. While the majority of patients improved with respect to both their affective and cognitive states, certain treatment-refractory subgroups were nevertheless identified.
  
  
  CONCLUSIONS
  The data suggest that cognitive dysfunction associated with depression may improve after treatment in a substantial number of elderly patients, including those receiving ECT. Relapse rates, however, may be relatively high, and residual symptoms may persist, which emphasizes the need for optimal initial and long-term antidepressant strategies for this population.
authors.affiliation: Medical-Psychiatric Unit, Emory University Hospital, Atlanta, GA.
authors.forename: A
authors.initials: A
authors.lastname: Stoudemire
authors.forename: C D
authors.initials: CD
authors.lastname: Hill
authors.forename: R
authors.initials: R
authors.lastname: Morris
authors.forename: D
authors.initials: D
authors.lastname: Martino-Saltzman
authors.forename: H
authors.initials: H
authors.lastname: Markwalter
authors.forename: B
authors.initials: B
authors.lastname: Lewison
mesh_terms: D000368:Aged; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D003071:Cognition; D003072:Cognition Disorders / Q000523:psychology / Q000628:therapy; D003131:Combined Modality Therapy; D003866:Depressive Disorder / Q000188:drug therapy / Q000523:psychology / Q000628:therapy*; D004565:Electroconvulsive Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D012008:Recurrence
chemical_list: D000929:Antidepressive Agents, Tricyclic